340B Program: Collision Course with Margins in 2026?
Is 340B hurting drug channels? Learn why the program's growth impacts pharma margins & what 2026 changes mean for providers.
Is 340B hurting drug channels? Learn why the program's growth impacts pharma margins & what 2026 changes mean for providers.
NHS plans a 2026 dementia care overhaul. Learn what's changing for diagnoses, support teams, and funding for families. Why it matters.
How can Atlanta fix health disparities? Explore 2026 policy fixes like Medicaid expansion & lead paint remediation, improving outcomes by 15%.
Did Trump's policies lower drug costs? A CBO report reveals limited impact, modest savings, and continued brand-name price hikes. What to know.
1 in 3 UK births face dementia. This £34.7B crisis demands 2026 reform: see policy changes for funding, training, and prevention.
Public Citizen challenges pharma's $370M lobbying in 2026. See how this fight for healthcare policy reform impacts drug prices and patient access.
Why do drug list prices like Tecfidera's $8,000 stay high? Learn how Medicare price negotiation and transparency efforts impact costs.
2026 brings new 'buy local' laws like the EU's IPI. Understand how economic nationalism impacts supply chains and market access now.
US drug costs are 2-4x higher than other nations. Learn why this is a moral failure, what solutions exist, and what's next for policy.
Why is the US cattle herd at a 50-year low? Understand the crisis impacting beef supply, prices, and food stability for 2026 and beyond.